The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of Aβ by Metal Ion Stripping and Redox Silencing
Open accessAbstract
Alzheimer's disease (AD) is the most common neurodegenerative disorder associated with cognitive decline and loss of memory. It is postulated that the generation of reactive oxygen species (ROS) in Fenton-like reaction connected with Cu(II)/Cu(I) redox cycling of the Cu(II)-aβ complex can play a key role in the molecular mechanism of neurotoxicity in AD. Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic regulatory peptide that possesses a high affinity for Cu(II) ions. The ability of the peptide Semax to inhibit the copper-catalyzed oxidation of aβ was studied in vitro and discussed. The results indicate that Semax is able to extract Cu(II) from Cu(II)-aβ species as well as to influence the redox cycling of the Cu(II)-aβ complex and decrease the level of associated ROS production. Finally, our data suggest that Semax shows cytoprotective properties for SH-SY5Y cells against oxidative stress induced by copper-catalyzed oxidation of the aβ peptide. This study provides valuable insights into the potential role of Semax in neurodegenerative disorders and into the design of new compounds with therapeutic potential for AD.
Overview
CoChat Summary
## TL;DR
Semax, a synthetic peptide with high affinity for Cu(II), reduced Cu(II)-catalyzed ROS generation and the resulting cytotoxicity of amyloid-β in vitro and in SH-SY5Y neuroblastoma cells. The paper argues this occurs by stripping Cu(II) from Aβ and “redox silencing” the copper, although some ROS production still remained under conditions where Cu(I) chelators were present.
## Key findings
- In cell-free assays, free Cu(II) caused complete ascorbate consumption and hydroxyl radical production after 30 min, while Aβ reduced both the rate and level of these reactions; Aβ fragments Aβ1–16, Aβ1–28, and Aβ1–40 behaved similarly, with no significant difference reported among them.
- Adding Semax inhibited Cu(II)-mediated ascorbate oxidation and HO• generation, and when Semax:Cu(II) was preformed, adding Aβ did not restore ascorbate consumption or HO• production; the paper reports a conditional dissociation constant of cKd = 1.3 × 10−15 M for Semax:Cu(II).
- In the presence of bicinchoninic acid (BCA), Cu(II) was readily reduced to Cu(I)-(BCA)2; however, if Cu(II)-Semax was already formed, reduction did not occur and no Cu(I)-(BCA)2 was detected after BCA addition.
- In SH-SY5Y cells, Cu(II) + ascorbate and Cu(II) + ascorbate + Aβ increased ROS-positive cells to 68% and 79%, respectively, versus about 10% in untreated cells; Semax reduced these to 41% and 40%. Cell viability dropped to 59% and 63% with Cu(II) + ascorbate and Cu(II) + ascorbate + Aβ, and Semax raised viability to 83% and 82%.
## Methods
- The study combined in vitro spectrophotometric and fluorometric assays with cell-based experiments to test how Semax affects Cu(II)-Aβ redox chemistry and oxidative toxicity.
- Peptides used included Semax, Aβ1–16, Aβ1–28, and Aβ1–40; SH-SY5Y human neuroblastoma cells were used for intracellular ROS detection and MTT viability assays.
- Main analyses included UV monitoring of ascorbate consumption, fluorescence detection of hydroxyl radical formation via 3-CCA/7-OH-CCA, UV-Vis competition experiments with BCA, flow cytometry with H2DCFDA for intracellular ROS, and MTT assay for cell viability; results were analyzed with one-way ANOVA/Tukey or chi-square tests.
## Limitations
- The paper states that Semax did not completely inhibit the Fenton–Haber–Weiss reaction in some conditions; even with Semax, “a small, but significant” consumption of ascorbate and production of OH• persisted.
- The text makes evident that several conclusions are based on in vitro chemistry and a single neuroblastoma cell line, so direct evidence in animal models or patients is not provided in this paper (evident from the reported methods/results).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
1 Valid · 0 Not valid · 3 Not checked · 18 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This behavior, showing that redox inert Cu(II) ATCUN motif is not enough to inhibit ROS production, has been previously shown and explained by other authors [57, 58].”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.2. Semax Inhibits OH• Generation and Ascorbate Consumption Induced by Cu2+ and aβ-Cu2+
What the sources say
- Not checked yetcites [57] source
Checked before — its earlier verdict is held back until a new check runs.
- Supportedcites [58] source
In Results and Discussion §2.1 (page not provided), the paper reports that AAH forms a redox-inert Cu(II) complex but fails to stop Cu(Aβ)-induced ascorbate consumption when added after it begins, because Cu(II) extraction from Aβ is slow. The Concluding Remarks (page not provided) likewise say that an ATCUN complex’s low ROS-forming ability is insufficient on its own: the rate of Cu(II) extraction also matters. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“thus, even if Semax is able to form redox inert Cu(II) complexes and to extract Cu(II) from aβ:Cu(II) complex, the Fenton–Haber–Weiss reaction was not completely inhibited (Figures 2(a) and 2(b), black curves).”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.2. Semax Inhibits OH• Generation and Ascorbate Consumption Induced by Cu2+ and aβ-Cu2+
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the presence of Semax, the copper redox cycling was completely silenced.”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.2. Semax Inhibits OH• Generation and Ascorbate Consumption Induced by Cu2+ and aβ-Cu2+
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The presence of aβ in the ascorbate solution produced a reduction in both the rate and the level of ascorbate consumption after the addition of Cu(II) (Figure 1(a), blue curve) and HO• production (Figure 2(b), blue curve).”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.1. Aβ-Cu2+–Induced ROS
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Exposure to Cu(II) + ascorbate and Cu(II) + ascorbate + aβ reduced the cells' viability to 59% and 63%, respectively, compared to the control.”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.5. Semax Prevents Cu(II)-Ascorbate and Cu(II) Ascorbate-aβ–Induced Cell Death in Cultured Neuroblastoma Cells
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
9 more claims
Create a free account to see all 22 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 7
- Probably not a substantial claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 3. Conclusion
“the presence of the ACTUN motif with a high affinity constant (cKd = 1.3 10–15 M) does not guarantee the complete copper redox silencing if Cu(I) chelator is present in solution.”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.2. Semax Inhibits OH• Generation and Ascorbate Consumption Induced by Cu2+ and aβ-Cu2+
“Semax is a peptide with ATCUN motif having [CuH−2L]2− as the only very stable complex species able to strongly chelate copper ions at physiological pH and a very negative formal redox potential [71].”
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855 · cited 1×
“Free radicals are generally acknowledged as serious threat for the correct cell functioning [90, 91].”
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614 · cited 1×
“It can convert radicals into nonradicals, for instance HO Transferring an electron to a nonradical species can also result in reactions that lead to the formation of radicals; however, these reactions are normally not efcient [77], unless they are catalyzed [78].”
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185 · cited 2×
“A β plays a key role in the metal ion–mediated ROS production during oxidative stress [24, 74–76].”
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120 · cited 1×
“Several studies have shown that the AD-afected brain contains elevated concentrations of transition metals accumulated in amyloid plaques, mainly copper, zinc, and iron, suggesting that these metal ions actively take part in the etiology of the pathology by interacting with a β peptide [3, 9, 12].”
Gaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729
Cited by
Wang, X.-Q., Wang, Y., Ye, Z.-H., Zhang, Z., & Cen, S.-F. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1868164 · Cited by 2
Jiang, X., Zhang, H., Ping, S., et al. (2026) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2026.113214 · Cited by 1
Li, B., Qiu, J., & Bai, X. (2026) · ACS Omega · doi:10.1021/acsomega.5c10804
Metadata
- Authors
- Tomasello, M. F., Di Rosa, M. C., Naletova, I., Sciacca, M. F. M., Giuffrida, A., Maccarrone, G., & Attanasio, F.
- Affiliations
- National Research Council (IT)
- University of Catania (IT)
- Corresponding author
- Attanasio, Francesco
- ORCID
- Venue
- Bioinorganic Chemistry and Applications
- Publisher
- Wiley
- Published
- 2025-01
- Volume
- 2025
- Issue
- 1
- Pages
- 4226220-4226220
- ISSN
- 1565-3633 (ISSN-L)
- 1687-479X
- PMC
- PMC12151629
- OpenAlex
- W4410974228
- Semantic Scholar
- 1d332b6269d46d8a917bda24f181ebee14e42824
- Cited by
- 3
- References
- 102
- Citations by year
- 2026: 3
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor, 153 d)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Bioinorganic Chemistry and Applications (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- Semax, Alzheimer's disease, amyloid-beta, Fenton-like reaction, reactive oxygen species, oxidative stress, SH-SY5Y cells, neuroprotection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of Aβ by Metal Ion Stripping and Redox Silencing. https://app.cochat.ai/papers/10.1155/bca/4226220
- The paper
- Tomasello, M. F., Di Rosa, M. C., Naletova, I., Sciacca, M. F. M., Giuffrida, A., Maccarrone, G., & Attanasio, F. (2025). Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of Aβ by Metal Ion Stripping and Redox Silencing. Bioinorganic Chemistry and Applications. https://doi.org/10.1155/bca/4226220
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.